Is Montek LC Kid (montelukast and levocetirizine) safe to use during the first trimester of pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Safety of Montek LC Kid in First Trimester Pregnancy

Montek LC Kid (montelukast and levocetirizine combination) should be avoided during the first trimester of pregnancy due to limited safety data on levocetirizine, while safer alternatives with better documented safety profiles are available. 1

Safety Profile of Individual Components

Montelukast in Pregnancy

  • Montelukast has a Pregnancy Category B classification with reassuring animal reproductive studies and limited human safety data 2
  • A published observational study including 9 patients on leukotriene receptor antagonists demonstrated no adverse events during pregnancy 2
  • A 2009 prospective study found that montelukast does not appear to increase the baseline rate of major malformations, though birth weight was lower in exposed infants 3
  • A 2017 Danish population study found no significant increased risk of congenital anomalies with montelukast exposure during pregnancy 4

Levocetirizine in Pregnancy

  • Limited specific safety data exists for levocetirizine use during the first trimester of pregnancy 1
  • The American Academy of Allergy, Asthma, and Immunology recommends avoiding levocetirizine during the first trimester if possible 1
  • First trimester is the most critical period for potential congenital malformations due to medication exposure 1

Recommended Alternatives During First Trimester

Preferred Antihistamines

  • If antihistamine treatment is necessary during pregnancy, chlorphenamine is often preferred due to its long safety record 1
  • Cetirizine and loratadine (FDA Pregnancy Category B) have more accumulated safety data than levocetirizine 1

Alternative Treatments for Allergic Rhinitis

  • Sodium cromolyn is considered a safe treatment for allergic rhinitis during pregnancy (Pregnancy Category B) 2
  • Intranasal corticosteroids may be used for nasal symptoms during pregnancy with a better safety profile than oral medications 2
  • If intranasal corticosteroids are initiated during pregnancy, intranasal budesonide (Pregnancy Category B) may be preferred 2

Management Algorithm for Allergic Rhinitis in First Trimester

  1. First-line approach:

    • Consider non-pharmacological approaches first 1
    • If medication is necessary, use antihistamines with established safety profiles (chlorphenamine, cetirizine, or loratadine) 1
  2. Second-line options:

    • Sodium cromolyn nasal spray (requires frequent dosing) 2
    • Intranasal corticosteroids (preferably budesonide) 2
  3. Avoid during first trimester:

    • Montek LC Kid (montelukast-levocetirizine combination) 1
    • Oral decongestants 2
    • Hydroxyzine 2

Important Considerations and Pitfalls

  • Benefit-risk assessment: The potential benefit of symptom relief must be weighed against potential risks to the fetus 1
  • Combination risk: Combining decongestants with acetaminophen or salicylates may increase risk of malformations 2
  • Common pitfall: Assuming all antihistamines have equivalent safety profiles during pregnancy 1
  • Montelukast recommendation: While montelukast alone may be considered for use in pregnancy when there has been a uniquely favorable pre-pregnancy response, the combination with levocetirizine lacks sufficient safety data for first trimester use 2

References

Guideline

Safety of Levocetirizine During First Trimester of Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.